Analyzing Genius Sports Limited (GENI)’s quick and current ratios

Genius Sports Limited (NYSE: GENI) closed the day trading at $5.52 down -0.90% from the previous closing price of $5.57. In other words, the price has decreased by -$0.05 from its previous closing price. On the day, 3178197 shares were traded.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Ratios:

For a better understanding of GENI, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.77 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 104.40. For the most recent quarter (mrq), Quick Ratio is recorded 1.34 and its Current Ratio is at 1.34. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Macquarie on December 21, 2023, initiated with a Outperform rating and assigned the stock a target price of $11.

On October 12, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.

On May 25, 2023, Lake Street started tracking the stock assigning a Buy rating and target price of $7.Lake Street initiated its Buy rating on May 25, 2023, with a $7 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GENI now has a Market Capitalization of 1.16B and an Enterprise Value of 1.07B. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.86 while its Price-to-Book (P/B) ratio in mrq is 2.01. Its current Enterprise Value per Revenue stands at 2.60 whereas that against EBITDA is 190.02.

Stock Price History:

Over the past 52 weeks, GENI has reached a high of $8.45, while it has fallen to a 52-week low of $3.55. The 50-Day Moving Average of the stock is 6.58, while the 200-Day Moving Average is calculated to be 6.13.

Shares Statistics:

Over the past 3-months, GENI traded about 2.28M shares per day on average, while over the past 10 days, GENI traded about 2.24M shares per day. A total of 209.12M shares are outstanding, with a floating share count of 154.75M. Insiders hold about 27.65% of the company’s shares, while institutions hold 57.13% stake in the company. Shares short for GENI as of Mar 15, 2024 were 5.92M with a Short Ratio of 2.60, compared to 5.1M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.82% and a Short% of Float of 3.85%.

Earnings Estimates

Current recommendations for the stock of the company come from 8 analysts. On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.07 and a low estimate of -$0.12, while EPS last year was -$0.12. The consensus estimate for the next quarter is -$0.03, with high estimates of $0 and low estimates of -$0.05.

Analysts are recommending an EPS of between -$0.05 and -$0.25 for the fiscal current year, implying an average EPS of -$0.18. EPS for the following year is -$0.04, with 8 analysts recommending between $0.1 and -$0.16.

Revenue Estimates

9 analysts predict $116.79M in revenue for the current quarter. It ranges from a high estimate of $117.7M to a low estimate of $114.97M. As of the current estimate, Genius Sports Limited’s year-ago sales were $97.23M, an estimated increase of 20.10% from the year-ago figure. For the next quarter, 9 analysts are estimating revenue of $94.02M, an increase of 8.30% less than the figure of $20.10% in the same quarter last year. There is a high estimate of $95M for the next quarter, whereas the lowest estimate is $91.02M.

A total of 9 analysts have provided revenue estimates for GENI’s current fiscal year. The highest revenue estimate was $483.6M, while the lowest revenue estimate was $479.05M, resulting in an average revenue estimate of $480.69M. In the same quarter a year ago, actual revenue was $412.98M, up 16.40% from the average estimate. Based on 8 analysts’ estimates, the company’s revenue will be $555.52M in the next fiscal year. The high estimate is $566.9M and the low estimate is $544.07M. The average revenue growth estimate for next year is up 15.60% from the average revenue estimate for this year.

Most Popular